Physician profile
Trevor J Derderian
NPI 1124346697
$359,426.96
in general payments reported to CMS, 2019-2025
26 companies · $89K in 2025
The $89K reported for 2025 was more than what 99% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,320 · 2020: $27K · 2021: $23K · 2022: $65K · 2023: $71K · 2024: $76K · 2025: $89K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $104K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $59K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $44K · Travel and Lodging: $17K · Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $104,471.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,567.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $43,875.00 |
| Travel and Lodging | $16,563.63 |
| Food and Beverage | $12,918.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $264,027.31 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $75,040.46 | 2019-2025 | Enroute Transcarotid Neuroprotection System, General - Therapies, Carotid Wallstent |
| Medtronic, INC. | $14,255.58 | 2021-2025 | Endurant Iis, Valiant Captivia, Nanocross Elite |
| Cook Medical LLC | $1,984.93 | 2019-2025 | Zenith Spiral-Z, Zenith |
| Shockwave Medical, INC | $1,272.59 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $442.22 | 2023-2024 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Angiodynamics, INC. | $280.93 | 2022-2024 | Auryon Laser System 100-120 Vac, Bioflo |
| Janssen Pharmaceuticals, INC | $266.35 | 2021-2024 | Xarelto |
| Lemaitre Vascular, INC. | $250.70 | 2024-2025 | Artegraft Vascular Graft, Trivex System |
| Bard Peripheral Vascular, INC. | $231.81 | 2019-2023 | Set Aspirex S 10f 110cm |
| Cardiovascular Systems INC. | $216.33 | 2021 | |
| Inspiremd Ltd | $156.45 | 2025 | Cguard Prime Carotid Stent System |
| Inari Medical, INC. | $155.71 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $153.66 | 2019 | |
| Cagent Vascular INC | $150.00 | 2025 | Serrantor |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $136.54 | 2020 | |
| Philips North America LLC | $116.72 | 2023 | |
| Janssen Scientific Affairs, LLC | $114.56 | 2021 | |
| Cardiva Medical, INC. | $34.85 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Endologix LLC | $30.57 | 2023 | |
| Becton, Dickinson and Company | $28.44 | 2022 | |
| Terumo Medical Corporation | $25.61 | 2020 | |
| Veryan Medical Incorporated | $15.84 | 2022 | |
| Laminate Medical Technologies INC. | $14.00 | 2025 | Vasq |
| E.R. Squibb & Sons, L.L.C. | $12.58 | 2020 | |
| Smith+Nephew, INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Derderian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.